COMMUNIQUÉS West-GlobeNewswire

Rapid Nutrition Expands Owned-Brand Portfolio Through AI-Driven Commercial Intelligence
28/07/2026
Initial rollout of the Premium Nutrition Pantry demonstrates the Company's strategy to accelerate owned-brand expansion, strengthen vertical integration and support long-term revenue growth LONDON, July 28, 2026 (GLOBE [...]
Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026
27/07/2026
-First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community- TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard" or [...]
Legacy Health Works LLC Announces Kylar Denae Williams, 2024 University of Arkansas Graduate, as Chief Executive Officer of the Family-Built, AI-Infused Healthcare Company
28/07/2026
From graduation cap to CEO in two years: Williams, who earned her Bachelor of Science in Human Development and Family Science in 2024, leads the Dallas-based one-stop healthcare workforce development and communication [...]
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
28/07/2026
Data reinforce durable responses, bladder preservation, low rate of disease progression, and favorable safety and tolerability in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer DALLAS, July [...]
BurnTide Launch 2026: New Weight Loss Support ACV Gummies In The USA, AU, UK | Burntide Supplement Facts And Highlights Ingredients.
28/07/2026
Burntide is announcing an effective and updated weight loss support supplement, Burntide Gummies, analyzing the natural ingredient profile, supplement facts, manufacturing information, Customer Service Support Details, [...]
ARCPOINT PROVIDES UPDATE ON MANAGEMENT CEASE TRADE ORDER APPLICATION AND DELAY IN FILING ANNUAL FINANCIAL STATEMENTS
28/07/2026
GREENVILLE, South Carolina, July 27, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) provides an update further to its news release dated July 15, 2026 (the “ MCTO Application [...]
Elevar Therapeutics Announces Three Abstracts Accepted for Presentation at ESMO Congress 2026
27/07/2026
FORT LEE, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
ORYZON Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026
27/07/2026
Positive clinical data presented at EHA for iadademstat in first line acute myeloid leukemia (AML); iadademstat+azacitidine+venetoclax resulted in 100% ORR, 89% CRc and 78% CR, including in patients with TP53 or RAS [...]
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
27/07/2026
July 27, 2026 Q2 2026 Group performance Comparable order intake declined 1%, due to timing of certain large orders Group sales of EUR 4.4 billion, reflecting 4% comparable sales growth Income from operations of EUR 609 [...]
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
27/07/2026
Cambridge, Massachusetts, July 27, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27/07/2026
RADNOR, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
27/07/2026
CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced [...]
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
27/07/2026
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the second quarter ended June 30, [...]
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
27/07/2026
Dr. Rooney, former immunology leader at Johnson & Johnson, will lead clinical development strategy across Kymera’s industry-leading oral immunology portfolio Jared Gollob, MD, will retire from his role after eight [...]
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
27/07/2026
Conference Call to Begin Today at 4:30 p.m. ET MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for [...]
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
27/07/2026
ALAMEDA, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed [...]
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
27/07/2026
CANTON, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports [...]
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, August 10, 2026, at 4:30 p.m. Eastern Time to report [...]
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
27/07/2026
BRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule [...]

Pages